| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +11.62% | +0.81% | +10.81% | +6.07% | — |
| 14d | 4 | +75.00% | +3.21% | -0.09% | +3.29% | +2.00% | — |
| 30d | 4 | +50.00% | +7.85% | +2.77% | +5.08% | +4.78% | — |
| 60d | 4 | +75.00% | +37.96% | +3.75% | +34.21% | +12.14% | — |
| 90d | 4 | +75.00% | +82.89% | +5.76% | +77.13% | +41.93% | — |
| 180d | 4 | +75.00% | +254.87% | +12.14% | +242.73% | +236.87% | — |
| 1y | 4 | +75.00% | +746.14% | +19.35% | +726.79% | +377.54% | — |
| 2y | 4(2 pending) | +100.00% | +1334.15% | +44.34% | +1289.81% | +1289.81% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NUTX NUTEX HEALTH INC. | SALE Chief Operating Officer | 452 | $72.10 | $32.6K | 6,481 | Apr 4, 2025 | Apr 14, 2025 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASE Chief Operating Officer | 5,950 | — | — | 10,200 | Mar 1, 2025 | Apr 14, 2025 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASE Chief Operating Officer | 2,125 | — | — | 6,933 | Mar 1, 2025 | Apr 14, 2025 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASE Chief Operating Officer | 575 | $17.40 | $10.0K | 4,808 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASE Chief Operating Officer | 1,300 | $17.85 | $23.2K | 4,233 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASEGRANT Stock grant | 63,750 | — | — | 63,750 | Jun 28, 2024 | Jun 28, 2024 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASE Chief Operating Officer | 20,000 | $0.54 | $10.8K | 29,333 | Jun 12, 2024 | Jun 13, 2024 ↗ | View → |
| NUTX NUTEX HEALTH INC. | PURCHASE Chief Operating Officer | 140,000 | $0.24 | $34.2K | 140,000 | Nov 15, 2023 | Nov 16, 2023 ↗ | View → |